Immunic Inc. | VTL - Interest Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Immunic Inc.

Immunic Inc. reported $800K in Interest Income for its fiscal quarter ending in March of 2023.


Interest Income Change
BioMarin Pharmaceutical BMRN:US USD 11.94M 3.23M
Dynavax Technologies DVAX:US USD 6.6M 2.27M
Immunic Inc. VTL:US USD 800K 102K
Regulus Therapeutics RGLS:US USD 415K 82K
Revance Therapeutics RVNC:US USD 2.97M 61K
Ultragenyx Pharmaceutical RARE:US USD 6.29M 92K
United Therapeutics UTHR:US USD 29.2M 8.4M